SCHEMBL24670690

SCHEMBL24670690

OCC1CCN(c2ncc(Br)cc2F)CC1

nearest known ligand 0.48

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 4/20 0.48
OPRK1 P41145 15/20 0.47
ACACB O00763 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30066350 1.00 PDE10A (0.48) PDE10AOPRK1ACACB
SCHEMBL31583655 0.84 OPRK1 (0.44) OPRK1ACACB
SCHEMBL25141835 0.80 ABL1 (0.39) PDE10A
SCHEMBL22907440 0.79 OPRK1 (0.45) OPRK1ACACB
SCHEMBL22907129 0.78 OPRK1 (0.38) OPRK1ACACB
SCHEMBL20354132 0.78 OPRK1 (0.40) OPRK1ACACB
SCHEMBL29414945 0.78 OPRK1 (0.40) OPRK1ACACB
SCHEMBL17316555 0.78 HTT (0.41) OPRK1ACACB
SCHEMBL24881373 0.77 OPRK1 (0.44) OPRK1ACACB
SCHEMBL25031006 0.77 TYMP (0.39) PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117693502-A Compounds for inhibiting or degrading ITK, compositions comprising the same, methods of making the same, and methods of using the same 纽力克斯治疗公司 2024-03-12 CN disclosed
WO-2022235715-A1 COMPOUNDS FOR INHIBITING OR DEGRADING ITK, COMPOSITIONS, COMPRISING THE SAME METHODS OF THEIR MAKING AND METHODS OF THEIR USE NURIX THERAPEUTICS, INC. (US) 2022-11-10 WO disclosed